Literature DB >> 9607420

Significant behavioral recovery in Parkinson's disease model by direct intracerebral gene transfer using continuous injection of a plasmid DNA-liposome complex.

T Imaoka1, I Date, T Ohmoto, T Nagatsu.   

Abstract

As an alternative to virus-mediated gene transfer, we previously demonstrated a simple, safe, and efficient transfer of foreign gene into the central nervous system using continuous injection of a plasmid DNA-cationic liposome complex. To explore whether this approach can be applied to the treatment of certain neurological disorders, we used an experimental model of Parkinson's disease (PD) in the present study. Following continuous injection for 7 days, tyrosine hydroxylase (TH) and aromatic L-amino acid decarboxylase (AADC) genes carried by a bovine papilloma virus-based plasmid vector were efficiently introduced into glial cells in the striatum of 6-hydroxydopamine-lesioned rats. Significant recovery in apomorphine-induced rotational behavior of PD models was obtained by transfection of TH gene and this effect continued for up to 5 weeks after injection. Moreover, cotransfection of TH with AADC genes was readily accomplished by this procedure and resulted in a greater and longer-lasting improvement of apomorphine-induced rotational behavior than was achieved by transfection of TH gene alone. We suggest that this approach is a controllable and manageable alternative to other methods of gene therapy for the treatment of PD.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9607420     DOI: 10.1089/hum.1998.9.7-1093

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  7 in total

1.  Correction of a rat model of Parkinson's disease by coexpression of tyrosine hydroxylase and aromatic amino acid decarboxylase from a helper virus-free herpes simplex virus type 1 vector.

Authors:  Mei Sun; Guo-Rong Zhang; Lingxin Kong; Courtney Holmes; Xiaodan Wang; Wei Zhang; David S Goldstein; Alfred I Geller
Journal:  Hum Gene Ther       Date:  2003-03-20       Impact factor: 5.695

Review 2.  Nonviral gene transfection nanoparticles: function and applications in the brain.

Authors:  Indrajit Roy; Michal K Stachowiak; Earl J Bergey
Journal:  Nanomedicine       Date:  2008-03-03       Impact factor: 5.307

3.  Bromocriptine markedly suppresses levodopa-induced abnormal increase of dopamine turnover in the parkinsonian striatum.

Authors:  N Ogawa; K Tanaka; M Asanuma
Journal:  Neurochem Res       Date:  2000-06       Impact factor: 3.996

Review 4.  Personalized nanomedicine for CNS diseases.

Authors:  Ajeet Kaushik; Rahul Dev Jayant; Vinay Bhardwaj; Madhavan Nair
Journal:  Drug Discov Today       Date:  2017-11-15       Impact factor: 7.851

Review 5.  Getting into the brain: liposome-based strategies for effective drug delivery across the blood-brain barrier.

Authors:  Débora B Vieira; Lionel F Gamarra
Journal:  Int J Nanomedicine       Date:  2016-10-18

6.  Optimizing NTS-polyplex as a tool for gene transfer to cultured dopamine neurons.

Authors:  Daniel Hernandez-Baltazar; Daniel Martinez-Fong; Louis-Eric Trudeau
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

Review 7.  Gene Therapy for Parkinson's Disease, An Update.

Authors:  Tobias M Axelsen; David P D Woldbye
Journal:  J Parkinsons Dis       Date:  2018       Impact factor: 5.568

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.